Anemia, a reduction in the number or hemoglobin content of red blood cells, is a common hematological disorder with diverse etiologies. It poses a diagnostic challenge due to its multifactorial nature, necessitating a comprehensive approach for accurate diagnosis.
The first step in the diagnostic approach involves a thorough history and physical examination. Key aspects include dietary habits, family history, signs of blood loss, and symptoms suggestive of systemic diseases. Laboratory investigations start with a complete blood count (CBC) and peripheral smear examination. Reticulocyte count and indices provide clues about the bone marrow response.
Anemia is classified as microcytic, normocytic, or macrocytic based on mean corpuscular volume (MCV). Microcytic anemia is often due to iron deficiency or thalassemia. Normocytic anemia may be due to acute blood loss or chronic disease, while macrocytic anemia is commonly due to vitamin B12 or folate deficiency.
Further investigations are guided by the initial findings. Iron studies, hemoglobin electrophoresis, or genetic testing may be necessary for microcytic anemia. For normocytic anemia, bone marrow examination may be required in cases of unexplained anemia. In macrocytic anemia, serum B12, folate levels, and a test for intrinsic factor antibodies may be indicated.
In patients with co-existing disorders like renal disease or malignancy, the diagnostic approach may need modification. For instance, in chronic kidney disease, erythropoietin levels may be helpful. In suspected malignancy, bone marrow examination is often warranted.
Unraveling the complexity of anemia requires a systematic approach, starting from a detailed history and physical examination, followed by basic investigations and then specific tests based on initial findings. Understanding the pathophysiological basis and being aware of the special situations can greatly aid in the diagnostic process, ensuring timely and appropriate management.
1.
In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".
2.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
3.
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer
4.
CAR T cells improve patients' quality of life: a study
5.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
1.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Bone Marrow Niche Remodeling in Hematologic Dysfunction
4.
Public Health Strategies for Expanding Early Support Systems in Blood Disorders
5.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation